Cleared Traditional

K881272 - ACCUSTAT MODEL 102 NON-INVASIVE BLOOD MONITORING

K881272 is an FDA 510(k) clearance for ACCUSTAT MODEL 102 NON-INVASIVE BLOOD M..., manufactured by Accustat, Inc.. The device is a Class 2 Cardiovascular device with product code DXN cleared through the Traditional 510(k) pathway after a 90-day FDA review.

K881272 · Accustat, Inc. · Cardiovascular device
Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Jun 1988
Decision
90d
Days
Class 2
Risk

K881272 is an FDA 510(k) clearance for the ACCUSTAT MODEL 102 NON-INVASIVE BLOOD MONITORING. Classified as System, Measurement, Blood-pressure, Non-invasive (product code DXN), Class II - Special Controls.

Submitted by Accustat, Inc. (Clearwater, US). The FDA issued a Cleared decision on June 22, 1988 after a review of 90 days - within the typical 510(k) review window.

This device falls under the Cardiovascular FDA review panel, regulated under 21 CFR 870.1130 - the FDA cardiovascular device oversight framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: Standard predicate-based submission. Standard predicate reliance. This clearance follows a standard predicate-based equivalence path within the Cardiovascular review framework, consistent with the majority of Class II 510(k) submissions.

View all Accustat, Inc. devices

FDA 510(k) Submission Details - K881272

510(k) Number K881272 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received March 24, 1988
Decision Date June 22, 1988
Days to Decision 90 days
Submission Type Traditional
Review Panel Cardiovascular (CV)
Summary -
Third-party Review No - reviewed directly by FDA
Regulatory Context
Review time vs. panel average
35d faster than avg
Panel avg: 125d · This submission: 90d
Pathway characteristics
Predicate-based equivalence. No clinical trials required.

DXN Device Classification - Class 2, Special Controls

Product Code DXN System, Measurement, Blood-pressure, Non-invasive
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 870.1130
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most Cardiovascular devices follow this clearance model.

Regulatory Peers - DXN System, Measurement, Blood-pressure, Non-invasive

All 917
Devices cleared under the same product code (DXN) and FDA review panel - the closest regulatory comparables to K881272.
POCKET MANOMETER
K880599 · Abbott Laboratories · Oct 1988
MODEL BPS08 BLOOD PRESSURE MODULE
K881155 · Fresenius USA, Inc. · Jul 1988
MODEL 404 ADULT HEART RATE/BLOOD PRESSURE MONITOR
K882188 · Ivy Biomedical Systems, Inc. · Jul 1988
PYTHON AMBULATORY BLOOD PRESSURE MONITORING SYSTEM
K874917 · Oxford Medilog, Inc. · May 1988
OHMEDA 2350 FINAPRES(R) BLOOD PRESSURE MONITOR
K880572 · Ohmeda Medical · May 1988
VITAL SYSTEM
K880351 · Pace Tech, Inc. · Mar 1988